Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: A systematic review and a meta-analysis

Clinical Neurology and Neurosurgery

Volumn 113, Issue 10, 2011, Pages 823-829

  Treglia, Giorgio ^a   Stefanelli, Antonella ^a   Cason, Ernesto ^b   Cocciolillo, Fabrizio ^a   Di Giuda, Daniela ^a   Giordano, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

Diagnostic accuracy; Meta analysis; Metaiodobenzylguanidine; MIBG; Multiple system atrophy; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

BRAIN SCINTISCANNING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; META ANALYSIS; PARKINSON DISEASE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW;

3-IODOBENZYLGUANIDINE; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 81155123057     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2011.09.004     Document Type: Review

References (41)

1. W.H. Jost, K. Del Tredici, C. Landvogt, and S. Braune Importance of 123I-metaiodobenzylguanidine scintigraphy/single photon emission computed tomography for diagnosis and differential diagnostics of Parkinson syndromes Neurodegener Dis 7 2010 341 347
2. G. Treglia, E. Cason, A. Gabellini, A. Giordano, and G. Fagioli Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases Neurol Sci 31 2010 417 422
3. S. Yamashina, and J. Yamazaki Neuronal imaging using SPECT Eur J Nucl Med Mol Imaging 34 2007 939 950 (Pubitemid 46798959)
4. K. Nakajima, M. Yoshita, S. Matsuo, J. Taki, and S. Kinuya Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders Q J Nucl Med Mol Imaging 52 2008 378 387
5. O. Rascol, and L. Schelosky 123I-Metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders Mov Disord 24 Suppl. 2 2009 S732 S741
6. N. Hishikawa, Y. Hashizume, M. Yoshida, and G. Sobue Clinical and neuropathological correlates of Lewy body disease Acta Neuropathol (Berl) 105 2003 341 350 (Pubitemid 36798828)
7. J. Zamora, V. Abraira, A. Muriel, K. Khan, and A. Coomarasamy Meta-DiSc: a software for meta-analysis of test accuracy data BMC Med Res Methodol 6 2006 31
8. M. Hirayama, S. Hakusui, Y. Koike, K. Ito, T. Kato, and M. Ikeda A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure J Auton Nerv Syst 53 1995 230 234
9. A. Druschky, M.J. Hilz, G. Platsch, M. Radespiel-Tröger, K. Druschky, and T. Kuwert Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT J Neurol Sci 175 2000 3 12 (Pubitemid 30227477)
10. F. Courbon, C. Brefel-Courbon, C. Thalamas, M.J. Alibelli, I. Berry, and J.L. Montastruc Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease Mov Disord 18 2003 890 897 (Pubitemid 37021163)
11. S. Saiki, G. Hirose, K. Sakai, S. Kataoka, A. Hori, and M. Saiki Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD J Neurol Sci 220 2004 105 111 (Pubitemid 38622107)
12. H. Matsui, F. Udaka, M. Oda, T. Kubori, K. Nishinaka, and M. Kameyama Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy Auton Neurosci 119 2005 56 60 (Pubitemid 40704699)
13. D.H. Shin, P.H. Lee, O.Y. Bang, I.S. Joo, and K. Huh Clinical implications of cardiac-MIBG SPECT in the differentiation of Parkinsonian syndromes J Clin Neurol 2 2006 51 57
14. P.H. Lee, S.H. Yeo, H.J. Kim, and H.Y. Youm Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy Mov Disord 21 2006 1975 1977 (Pubitemid 44848949)
15. F. Yamashita, M. Hirayama, T. Nakamura, M. Takamori, N. Hori, and K. Uchida Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests Clin Auton Res 20 2010 191 197
16. C. Marini, M. Bandettini di Poggio, E. Pomposelli, R. Marchese, F. Nobili, and S.D. Morbelli Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging Clin Nucl Med 35 2010 311 316
17. K. Ishibashi, Y. Saito, S. Murayama, K. Kanemaru, K. Oda, and K. Ishiwata Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET Eur J Nucl Med Mol Imaging 37 2010 3 11
18. H. Sawada, T. Oeda, K. Yamamoto, N. Kitagawa, E. Mizuta, and R. Hosokawa Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease Eur J Neurol 16 2009 174 182
19. S. Nagamachi, H. Wakamatsu, S. Kiyohara, S. Fujita, S. Futami, and S. Tamura Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy Ann Nucl Med 22 2008 557 564
20. S. Braune, M. Reinhardt, R. Schnitzer, A. Riedel, and C.H. Lücking Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy Neurology 53 1999 1020 1025 (Pubitemid 29442118)
21. M.J. Reinhardt, F.D. Jüngling, T.M. Krause, and S. Braune Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake Eur J Nucl Med 27 2000 595 600 (Pubitemid 30262627)
22. I. Fröhlich, W. Pilloy, M. Vaillant, and N.J. Diederich Myocardial MIBG scintigraphy: a useful clinical tool?: a retrospective study in 50 parkinsonian patients Neurol Sci 31 2010 403 406
23. E.J. Chung, W.Y. Lee, W.T. Yoon, B.J. Kim, and G.H. Lee MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy Mov Disord 24 2009 1650 1655
24. T. Miyamoto, M. Miyamoto, K. Suzuki, M. Nishibayashi, M. Iwanami, and K. Hirata 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder Sleep 31 2008 717 723 (Pubitemid 351694259)
25. M. Köllensperger, K. Seppi, C. Liener, S. Boesch, D. Heute, and K.J. Mair Diffusion weighted imaging best discriminates PD from MSA-P: a comparison with tilt table testing and heart MIBG scintigraphy Mov Disord 22 2007 1771 1776 (Pubitemid 47597601)
26. K. Kashihara, M. Ohno, S. Kawada, and Y. Okumura Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies J Nucl Med 47 2006 1099 1101 (Pubitemid 47544904)
27. H. Nagayama, M. Hamamoto, M. Ueda, J. Nagashima, and Y. Katayama Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease J Neurol Neurosurg Psychiatry 76 2005 249 251 (Pubitemid 40143717)
28. H. Takatsu, K. Nagashima, M. Murase, H. Fujiwara, H. Nishida, and H. Matsuo Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation JAMA 284 2000 44 45 (Pubitemid 30445658)
29. J. Taki, K. Nakajima, E.H. Hwang, I. Matsunari, K. Komai, and M. Yoshita Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific Eur J Nucl Med 27 2000 566 573 (Pubitemid 30262623)
30. S. Orimo, E. Ozawa, S. Nakade, T. Sugimoto, and H. Mizusawa (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease J Neurol Neurosurg Psychiatry 67 1999 189 194 (Pubitemid 29326950)
31. M. Yoshita Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy J Neurol Sci 155 1998 60 67 (Pubitemid 28141060)
32. H.J. Verberne, L.M. Brewster, G.A. Somsen, and B.L. van Eck-Smit Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review Eur Heart J 29 2008 1147 1159 (Pubitemid 351844881)
33. G. Treglia, and E. Cason Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with Lewy bodies and other dementias: a systematic review and a meta-analysis J Neuroimaging November 2010 10.1111/j.1552-6569.2010.00532.x [Epub ahead of print]
34. K.K. Solanki, J. Bomanji, J. Moyes, S.J. Mather, P.J. Trainer, and K.E. Britton A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG) Nucl Med Commun 13 1992 513 521
35. S. Orimo, T. Kanazawa, A. Nakamura, T. Uchihara, F. Mori, and A. Kakita Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy Acta Neuropathol 113 2007 81 86 (Pubitemid 44782932)
36. K. Sakata, K. Iida, N. Mochizuki, M. Ito, and Y. Nakaya Physiological changes in human cardiac sympathetic innervation and activity assessed by 123I-Metaiodobenzylguanidine (MIBG) imaging Circ J 73 2009 310 315
37. S. Braune The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes Clin Auton Res 11 2001 351 355 (Pubitemid 34461714)
38. H. Nagayama, M. Ueda, M. Yamazaki, Y. Nishiyama, M. Hamamoto, and Y. Katayama Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy Mov Disord 25 2010 1744 1747
39. V. Marshall, and D. Grosset Role of dopamine transporter imaging in routine clinical practice Mov Disord 18 2003 1415 1423 (Pubitemid 38035363)
40. I.U. Isaias, and A. Antonini Single-photon emission computed tomography in diagnosis and differential diagnosis of Parkinson's disease Neurodegener Dis 7 2010 319 329
41. M. Südmeyer, C. Antke, T. Zizek, M. Beu, S. Nikolaus, and L. Wojtecki Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach J Nucl Med 52 2011 733 740